Skip to main content
SpringerLink
Log in

Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

We aimed to compare the efficacy of intra-articular injections of a lower molecular weight hyaluronan (LMW HA) (Ostenil) with a higher molecular weight viscosupplement (hylan G-F 20, Synvisc) in hip osteoarthritis. For this purpose, 43 patients (56 hips) with hip osteoarthritis with a visual analogue scale (VAS) pain score higher than 50/100, a Lequesne index greater than 6, and persistence of the pain for longer than 3 months despite all conservative methods were enrolled in the study and randomly assigned to two groups: 25 (32 hips) received LMW HA and the remaining 18 patients (24 hips) received hylan G-F 20. Three injections were administered once weekly to each patient under fluoroscopic guidance. During the 6-month follow-up period, the primary outcomes were assessed at the 1st, 3rd, and 6th month by VAS, WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index), and Lequesne index. The intra-articular injections produced a significant reduction in VAS, WOMAC, and Lequesne index scores in both groups. After three injections, improvement was prominent at the 1st month and maintained for 6 months in both groups. The percentage reduction was 38 and 40% (p<0.001) in VAS pain score, 43 and 40% in WOMAC (p<0.001), and 47 and 49% in Lequesne index (p<0.001) in the LMW HA and hylan G-F groups at the 6th month, respectively. However, there were no significant differences in outcomes between any of the measurements at the 1st, 3rd, and 6th month between the two groups (p>0.05). No systemic adverse effect was recorded. Local adverse effects consisting of pain and/or swelling were noted in 3 of 32 hips (9%) injected with LMW HA and in 3 of 24 hips (12.5%) injected with hylan G-F 20. In conclusion, both types of viscosupplementation produced a significant clinical improvement during the 6-month follow-up period. However, no significant difference was found in outcomes between higher and lower molecular weight hyaluronan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Thomas E, Wilkie R, Peat G, Hill S, Dziedzic K, Croft P (2004) The North Staffordshire Osteoarthritis Project—NorStOP: prospective, 3-year study of the epidemiology and management of clinical osteoarthritis in a general population of older adults. BMC Musculoskelet Disord 5:2

    Article  Google Scholar 

  2. Ling SM, Bathon JM (1998) Osteoarthritis in older adults. J Am Geriatr Soc 46:216–225

    Google Scholar 

  3. Pelletier JP, Martel-Pelletier J (1993) The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol 20:19–23

    Google Scholar 

  4. Kirvan J (2001) Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee 8:93–101

    CAS  PubMed  Google Scholar 

  5. Balazs EA, Denlinger Jl (1993) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 20:3–9

    Google Scholar 

  6. Frizziero L, Govoni E, Bachin P (1998) Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 16:441–449

    Google Scholar 

  7. Altman RD, Moskowitz R (1998) Intra-articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 25:2203–2212

    Google Scholar 

  8. Tasciotaoglu F, Oner C (2003) Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 22:112–117

    Google Scholar 

  9. Neustadt DH (2003) Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 21:307–311

    Google Scholar 

  10. Maheu E, Ayral X, Dougados M (2002) A hyaluronan preparation (500–730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 56:804–813

    Google Scholar 

  11. Balazs EA, Leshchiner A (1992) Biomatrix, Inc., assigne. Hylan preparation and method of recovery there of from animal tissues. US Patent 5, 099, 013 24 March 1992

  12. Balazs EA, Leshchiner EA (1989) Hyaluronan, its cross-linked derivate-hylan-and their medical applications. In: Inagaki H, Phillips GO (eds) Cellulosics utilization: research and rewards in cellulosics. Proceedings of Nisshinbo International Conference on Cellulosics Utilization in the Near Future. Elsevier Applied Science, New York, pp 233–241

    Google Scholar 

  13. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, Vetter G, Balazs E (1999) The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21:1549–1562

    CAS  PubMed  Google Scholar 

  14. Vad VB, Sakalkale D, Sculco TP, Thomas L (2003) Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84:1224–1226

    Article  Google Scholar 

  15. Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L (2002) Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69:388–391

    PubMed  Google Scholar 

  16. Caglar-Yagci H, Unsal S, Yagci I, Dulgeroglu D, Ozel S (2004) Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 in osteoarthritis of the hip: a pilot study. Rheumatol Int DOI: 10.1007/s00296-004-0441-5

    Google Scholar 

  17. Conrozier T, Bertin B, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol 21:605–610

    CAS  PubMed  Google Scholar 

  18. Bayramoğlu M, Karataş M, Çetin N, Akman N, Sözay S, Dilek A (2003) Comparison of two different viscosupplements in knee osteoarthritis—a pilot study. Clin Rheumatol 22:118–122

    Google Scholar 

  19. Karlsson J, Sjögren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41:1240–1248

    Google Scholar 

  20. Altman R, Alarcon G, Appelrouth D (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514

    CAS  PubMed  Google Scholar 

  21. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthritis. Ann Rheum Dis 16:495–501

    Google Scholar 

  22. Price DD, Hawkins SW (1987) Combined use of experimental pain and visual analog scales in providing standardized measurements of clinical pain. Clin J Pain 3:1–8

    Google Scholar 

  23. Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation—value in comparison with other assessment tests. Scand J Rheumatol Suppl 65:85–89

    CAS  PubMed  Google Scholar 

  24. Nicholas Bellamy, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes of anti-rheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840

    CAS  PubMed  Google Scholar 

  25. Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritic: are the effects molecular weight dependent? Semin Arthritis Rheum 32:10–37

    Article  Google Scholar 

  26. Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20:410–423

    Article  Google Scholar 

  27. Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT (2001) Efficacy and safety of intra-articular sodium hyaluronate in knee osteoarthritis. Clin Orthop 385:130–143

    PubMed  Google Scholar 

  28. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, Odensten M, Ryd L, Sernbo I, Suomalainen O, Tegnander A (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo-controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55:424–431

    Google Scholar 

  29. Migliore A, Martin LSM, Alimonti A, Valente C, Tormenta S (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305–306

    CAS  PubMed  Google Scholar 

  30. Bernard TN, Kirkaldis-Waldis WH (1987) Recognizing specific characteristics of nonspecific low back pain. Clin Orthop 217:226–280

    Google Scholar 

  31. Namik O, Toyosima H, Morisaki N (1982) Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid in osteoarthritis of the knee. J Clin Pharm Ther Toxicol 20:501–507

    Google Scholar 

  32. Chevalier X, Conrozier T, Bertin P, Bailleul F, Vignon E (2000) Treatment of patients with symptomatic hip OA. A pilot study with intra-articular hylan G-F 20 (Synvisc). Arthritis Rheum 43 [Suppl]:384

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Faculty of Medicine, University of Celal Bayar, Manisa, Turkey

    Canan Tıkız, Zeliha Ünlü, Aslı Şener & Çiğdem Tüzün

  2. Department of Physical Medicine and Rehabilitation, SSK Hospital, Manisa, Turkey

    Murat Efe

  3. 1748 sokak, 26/4, 35530, Karsıyaka, İzmir, Turkey

    Canan Tıkız

Authors
  1. Canan Tıkız
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeliha Ünlü
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aslı Şener
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murat Efe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Çiğdem Tüzün
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Canan Tıkız.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tıkız, C., Ünlü, Z., Şener, A. et al. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 24, 244–250 (2005). https://doi.org/10.1007/s10067-004-1013-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-1013-5

Keywords

Search

Navigation